Pillstats
Rx only · Tablet, Film Coated · Oral

Losartan Potassium

Brands: Cozaar · Losortan Potassium · Losartan Potassium

34 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US166 NDCs
34 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)52175
US makers34 labelers
Packages420
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 86 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.091$0.183$0.274$0.366Dec 2025Mar 2026Jul 2026
$0.317
Latest avg · Jul 22, 2026
+891%
Since Dec 17, 2025
34
Active US suppliers
25%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

713K1.4M2.1M2.9M2025 Q12025 Q22025 Q32025 Q42026 Q1
2.2M
Rx · 2026 Q1
123.2M
Units dispensed
-6%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it34 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager71SUPPLYING
Proficient Rx LPunknown32SUPPLYING
Preferred Pharmaceuticals Inc.unknown26SUPPLYING
A-S Medication Solutionsunknown24SUPPLYING
Alembic Pharmaceuticals Limitedunknown24SUPPLYING
Aphena Pharma Solutions - Tennessee, LLCunknown21SUPPLYING
REMEDYREPACK INC.repackager17SUPPLYING
NuCare Pharmaceuticals, Inc.unknown16SUPPLYING
Zydus Lifesciences Limitedunknown15SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown15SUPPLYING
Camber Pharmaceuticals, Inc.unknown15SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown14SUPPLYING
Macleods Pharmaceuticals Limitedunknown12SUPPLYING
Solco Healthcare US, LLCunknown11SUPPLYING
Direct_Rxunknown9SUPPLYING

+ 19 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 26, 2023
    RECALLRecall (Class II): Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sci…

    Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet. — Recalling firm: Strides Pharma Inc. — Nationwide in the USA.

  • Jun 6, 2022
    RECALLRecall (Class II): Losartan Potassium Tablets, USP 100 mg, 90 Tablets bottles, Rx Only, Marketed and Packaged By: PD-Rx Pharmaceuticals, I…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: PD-Rx Pharmaceuticals, Inc. — Nationwide

  • Jun 6, 2022
    RECALLRecall (Class II): Losartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-Rx Pharmaceuticals, Inc…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: PD-Rx Pharmaceuticals, Inc. — Nationwide

  • Jun 6, 2022
    RECALLRecall (Class II): Losartan Potassium Tablets, USP 25 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-Rx Pharmaceuticals, Inc…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: PD-Rx Pharmaceuticals, Inc. — Nationwide

  • May 18, 2022
    RECALLRecall (Class II): Losartan Potassium Tablets, USP, 100 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: Strides Pharma Inc. — Nationwide

  • May 18, 2022
    RECALLRecall (Class II): Losartan Potassium Tablets, USP 25 mg, Rx only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101,…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: Strides Pharma Inc. — Nationwide

  • May 18, 2022
    RECALLRecall (Class II): Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101,…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: Strides Pharma Inc. — Nationwide

  • Apr 15, 2022
    RECALLRecall (Class II): Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottles (NDC # 33342-045-07), b) 90-count bottles (NDC # 33342-045-…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: Macleods Pharma Usa Inc — Product was distributed nationwide.

  • Apr 15, 2022
    RECALLRecall (Class II): Losartan Potassium Tablets, USP, 100 mg, a) 30-count bottles (NDC # 33342-046-07), b) 90-count bottles (NDC # 33342-046…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: Macleods Pharma Usa Inc — Product was distributed nationwide.

  • Apr 15, 2022
    RECALLRecall (Class II): Losartan Potassium Tablets, USP, 25 mg, a) 90-count bottles (NDC # 33342-044-10), b) 1000-count bottles (NDC # 33342-04…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: Macleods Pharma Usa Inc — Product was distributed nationwide.

  • Jun 20, 2019
    RECALLRecall (Class II): Losartan Potassium Tablets, USP 50 mg 90 tablets Rx Only Manufactured for: Macleods Pharma USA inc. Plainsboro, NJ 0853…

    CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products. — Recalling firm: Macleods Pharma Usa Inc — Nationwide

  • Jun 20, 2019
    RECALLRecall (Class II): Losartan Potassium Tablets 50 mg 1000 Tablets, USP Rx Only Manufactured for: Macleods Pharma USA inc. Plainsboro, NJ 0…

    CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products. — Recalling firm: Macleods Pharma Usa Inc — Nationwide

  • Mar 8, 2019
    RECALLRecall (Class II): Losartan Potassium USP, 50 mg, RX Only, Pkg By PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 60 Tablet…

    CGMP deviation: Product found to contain trace amounts of NMBA — Recalling firm: PD-Rx Pharmaceuticals, Inc. — AK, AZ, CA, CO, FL, KY, MA, MI, MN, NC, OH, OR, WI, WY

  • Feb 28, 2019
    RECALLRecall (Class II): Losartan Potassium Tablets USP, 25 mg, Rx only, a) 90 count (NDC 31722-700-90), b) 500 count (NDC 31722-700-05) and c) …

    CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) detected in the active pharmaceutical ingredient — Recalling firm: Camber Pharmaceuticals Inc — Nationwide

  • Feb 28, 2019
    RECALLRecall (Class II): Losartan Potassium Tablets USP, 50 mg, Rx only, a) 30 count (NDC 31722-701-30), b) 90 count (NDC 31722-701-90), c) 1000…

    CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) detected in the active pharmaceutical ingredient — Recalling firm: Camber Pharmaceuticals Inc — Nationwide

  • Feb 28, 2019
    RECALLRecall (Class II): Losartan Potassium Tablets USP, 100 mg, Rx only, a) 30 count (NDC 31722-702-30), b) 90 count (NDC 31722-702-30), c) 100…

    CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) detected in the active pharmaceutical ingredient — Recalling firm: Camber Pharmaceuticals Inc — Nationwide

  • Sep 22, 2014
    RECALLRecall (Class II): LOSARTAN POTASSIUM TABLETS USP, 25 mg, 1000 Tablet Bottles, Rx Only. Manufactured by: Micro Labs Limited, Goa-403 722, …

    Failed Content Uniformity Specifications; Dry mix failed blend uniformity. — Recalling firm: Micro Labs Usa, Inc S — U.S. Including: New York